David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Oxford Industries
OXM
$546M
| $571K | ﹤0.01% |
+8,983
| New | +$548K |
|
2802
Brown & Brown
BRO
$25B
| $568K | ﹤0.01% |
23,588
-23,290
| -50% | -$523K |
|
2803
Hawkins
HWKN
$2.46B
| $568K | ﹤0.01% |
27,862
+18,038
| +184% | +$371K |
|
|
TSRO
2804
DELISTED
TESARO, Inc.
TSRO
| $568K | ﹤0.01% |
4,401
+1,001
| +29% | +$124K |
|
2805
PPG Industries
PPG
$25.2B
| $567K | ﹤0.01% |
+5,219
| New | +$556K |
|
2806
PUT
Veeva Systems
VEEV
$40.4B
| $564K | ﹤0.01% |
10,000
-10,000
| -50% | -$607K |
|
|
INFI
2807
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $561K | ﹤0.01% |
421,544
-4,018
| -0.9% | -$4.99K |
|
2808
CALL
Synaptics
SYNA
$3.66B
| $560K | ﹤0.01% |
14,300
+4,300
| +43% | +$194K |
|
2809
Rexford Industrial Realty
REXR
$8.4B
| $555K | ﹤0.01% |
+19,403
| New | +$556K |
|
2810
CALL
Oneok
OKE
$58.6B
| $554K | ﹤0.01% |
10,000
| – | – |
|
|
HSKA
2811
DELISTED
Heska Corp
HSKA
| $553K | ﹤0.01% |
6,278
-600
| -9% | -$59K |
|
2812
CALL
Motorola Solutions
MSI
$79.7B
| $552K | ﹤0.01% |
6,500
| – | – |
|
2813
CALL
GoPro
GPRO
$111M
| $551K | ﹤0.01% |
50,000
| – | – |
|
|
VSA
2814
VisionSys AI
VSA
$9.64M
| $550K | ﹤0.01% |
15
-22
| -59% | -$925K |
|
|
HIVE
2815
DELISTED
Aerohive Networks
HIVE
| $550K | ﹤0.01% |
134,343
-47,238
| -26% | -$189K |
|
2816
Gartner
IT
$12.8B
| $549K | ﹤0.01% |
+4,410
| New | +$545K |
|
2817
Snap-on
SNA
$20.4B
| $549K | ﹤0.01% |
3,682
-33,853
| -90% | -$5.09M |
|
2818
Northern Trust
NTRS
$34.2B
| $548K | ﹤0.01% |
5,959
+3,501
| +142% | +$316K |
|
2819
PUT
Marriott Vacations Worldwide
VAC
$3.93B
| $548K | ﹤0.01% |
4,400
-30,900
| -88% | -$3.56M |
|
2820
Spectrum Brands
SPB
$2.03B
| $547K | ﹤0.01% |
5,161
+2,446
| +90% | +$275K |
|
|
TRUE
2821
PUT
DELISTED
TrueCar
TRUE
| $546K | ﹤0.01% |
34,600
+3,200
| +10% | +$57.2K |
|
|
TWNK
2822
CALL
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $546K | ﹤0.01% |
40,000
| – | – |
|
|
IMH
2823
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $542K | ﹤0.01% |
41,508
-261
| -0.6% | -$3.63K |
|
|
GRMN
2824
CALL
Garmin
GRMN
$56.2B
| $540K | ﹤0.01% |
10,000
| – | – |
|
|
GRMN
2825
PUT
Garmin
GRMN
$56.2B
| $540K | ﹤0.01% |
10,000
| – | – |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.